Showing results (2161-2170 of 2,234) with videos related to

Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|December 27, 2007
Long-term biokinetics and radiation exposure of patients undergoing 14C-glycocholic acid and 14C-xylose breath testsMikael Gunnarsson, Sigrid Leide-Svegborn, Kristina Stenström, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 27, 2007
RNAi-mediated gene silencing of vascular endothelial growth factor inhibits growth of colorectal cancerWei Lv, Chao Zhang, Ding-Hua Zhou, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 10, 2014
Peptide receptor radionuclide therapy in patients with inoperable meningiomas: our experience and review of the literatureFabio Minutoli, Ernesto Amato, Alessandro Sindoni, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 28, 2019
Pyrroline-5-Carboxylate Reductase 1 Accelerates the Migration and Invasion of Nonsmall Cell Lung Cancer In VitroSenhua Sang, Cuicui Zhang, Jianwei Shan
Cancer Biotherapy & Radiopharmaceuticals|November 12, 2021
Long Noncoding RNAs PTPRG Antisense RNA 1 Targets Cyclin D1 to Facilitate Cell Proliferation in Lung AdenocarcinomaYang Xue, Mingqiang Diao, Jing Lyu, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 2, 2012
Compton scattering by internal shields based on melanin-containing mushrooms provides protection of gastrointestinal tract from ionizing radiationEkaterina Revskaya, Peter Chu, Robertha C Howell, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 2, 2012
Bax is essential for death receptor-mediated apoptosis in human colon cancer cellsShunqin Zhu, Tai Li, Juan Tan, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 13, 2012
Lysyl oxidase may play a critical role in hypoxia-induced NSCLC cells invasion and migrationLing Wei, Xian-Rang Song, Ju-Jie Sun, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 4, 2014
Using a single parameter to describe time-activity curvesCheuk S Kwok, Paul H Frankel, George Lopatin, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 28, 2014
Sequential radioimmunotherapy with 177Lu- and 211At-labeled monoclonal antibody BR96 in a syngeneic rat colon carcinoma modelSophie E Eriksson, Erika Elgström, Tom Bäck, et al.
Pageof 224